-
Mashup Score: 1
Nearly all treated patients received glucocorticoids, but many quickly needed later-line therapies, especially those with non-incident pulmonary sarcoidosis.
Source: www.hcplive.comCategories: General Medicine NewsTweet
-
Mashup Score: 1
Nearly all treated patients received glucocorticoids, but many quickly needed later-line therapies, especially those with non-incident pulmonary sarcoidosis.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
New at #ATS2025: New research is shedding light on real-world treatment patterns for #PulmonarySarcoidosis with parenchymal involvement in the US, highlighting high rates of glucocorticoid use and the frequent need for later-line therapies. 🔗View here: https://t.co/WSQrm49lYs
-
-
Mashup Score: 4
These data, presented at ATS 2025, highlight the efficacy results of methotrexate when compared to prednisone for pulmonary sarcoidosis.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
NEW from #ATS2025: New data suggests methotrexate may serve as an effective alternative to prednisone for #PulmonarySarcoidosis, with similar disease control and fewer side effects. 🔗View our summary here: https://t.co/dkyiiXkiJ6
-
New at #ATS2025: New research is shedding light on real-world treatment patterns for #PulmonarySarcoidosis with parenchymal involvement in the US, highlighting high rates of glucocorticoid use and the frequent need for later-line therapies. 🔗View here: https://t.co/WSQrm49lYs